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Background: Apelin, and its receptor APJ, are a peptidic system playing a crucial role in vascular dis-
eases.However, the roleof apelin in atherogenesis and smoothmuscle cell (SMC)proliferation remains
unclear.We isolated 2 distinct SMC phenotypes from porcine coronary artery: spindle-shaped (S) and
rhomboid (R). Biological features of R-SMCs (i.e. enhanced proliferative andmigratory activities aswell
as poor level of differentiation) explain their capacity to accumulate into the intima. S100A4 is amarker
of R-SMCs in vitro and of intimal SMCs, both in pig and human. S100A4 is a Ca2+-binding protein that
can also be secreted; it has extracellular functions probably via the receptor for advanced glycation end
products (RAGE).
Purpose: Investigate the effects of apelin on SMC phenotypic transition and S100A4 expression and
release.
Methods and Results:Weobserved that apelin was highly expressed in R-SMCs particularly in their
nucleus. P-SORT software analysis of preproapelin sequence suggested that N-terminal truncated
apelin may target the nucleus, and we confirmed this in SMCs by overexpression of mutated
preproapelin-His-tag. Transfection ofmutated preproapelin-His-tag encoding plasmid in differentiated
S-SMCs induced a transition towards a R-phenotype associated with increased proliferative activity,
downregulation of SMC differentiation markers (i.e. alpha-smooth muscle actin), and increased
nuclear expression and release of S100A4. In contrast, transfection of S-SMCs with wild type
preproapelin-His-tag encoding plasmid did not induce nuclear targeting of Apelin or S100A4,
and did not change the S-phenotype. Stimulation of S-SMCs with PDGF-BB, known to induce a
transition to the R-phenotype, yielded nuclear targeting of both apelin and S100A4. In vivo, Apelin
was expressed in SMC nuclei of stent-induced intimal thickening while its expression in the media
was mainly cytoplasmic.
Conclusions:Our results suggest that nuclear targeting of apelin in SMCs acts on S100A4 expression
and release, cell proliferation anddifferentiation. Thepathophysiological consequencesof this retarget-
ing could be instrumental in the understanding of artherosclerosis.
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